UMB Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
UMB Bank's NVO Position: Q2 2026 in Review
UMB Bank increased its Novo Nordisk (NVO) stake by 0.63% in Q2 2026, buying an estimated $14.6K and bringing the position to 54,146 shares worth $2.6M. The position accounts for 0.03% of the portfolio, ranked #244.
UMB Bank first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.03M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- UMB Bank held 54,146 shares of Novo Nordisk worth $2.6M as of Q2 2026.
- UMB Bank bought 339 Novo Nordisk shares in Q2 2026, an estimated $14.6K.
- Novo Nordisk made up 0.03% of UMB Bank's portfolio in Q2 2026, its #244 holding.
- UMB Bank first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
- UMB Bank's Novo Nordisk position peaked at $6.03M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.